Is the medical use of cannabis a therapeutic option for children?

被引:22
|
作者
Rieder, Michael J. [1 ]
机构
[1] Canadian Paediat Soc, 100-2305 St Laurent Blvd, Ottawa, ON K1G 4J8, Canada
关键词
Cannabinoids; Children; Epilepsy; Medical marijuana; Nabiximols; Smoking; HIGH-POTENCY CANNABIS; MULTIPLE-SCLEROSIS; MARIJUANA; SYMPTOMS; SCIENCE; TRENDS; IMPACT; STATE;
D O I
10.1093/pch/21.1.31
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Cannabis is a psychoactive compound with a long history of recreational and therapeutic use. Current considerations regarding cannabis use for medical purposes in children have been stimulated by recent case reports describing its beneficial effect with refractory epilepsy. Overall, there are insufficient data to support either the efficacy or safety of cannabis use for any indications in children, and an increasing body of data suggests possible harm, most importantly in specific conditions. The potential for cannabis as a therapeutic agent must be evaluated carefully for both efficacy and safety in treating specific paediatric health conditions. Smoking is not an acceptable mode of drug delivery for children. The use of cannabis for medical purposes in specific cases should not be construed as a justification for recreational cannabis use by adolescents. Recommendations for therapeutic use in exceptional paediatric cases are offered, always providing that this treatment course is carefully evaluated in individuals and in ongoing, well-designed research studies to determine safety and efficacy.
引用
收藏
页码:31 / 34
页数:4
相关论文
共 50 条
  • [31] Use and caregiver-reported efficacy of medical cannabis in children and adolescents in Switzerland
    Kathrin Zürcher
    Carole Dupont
    Peter Weber
    Sebastian Grunt
    Ilca Wilhelm
    Daniela E. Eigenmann
    Martina L. Reichmuth
    Manfred Fankhauser
    Matthias Egger
    Lukas Fenner
    [J]. European Journal of Pediatrics, 2022, 181 : 335 - 347
  • [32] Use and caregiver-reported efficacy of medical cannabis in children and adolescents in Switzerland
    Zurcher, Kathrin
    Dupont, Carole
    Weber, Peter
    Grunt, Sebastian
    Wilhelm, Ilca
    Eigenmann, Daniela E.
    Reichmuth, Martina L.
    Fankhauser, Manfred
    Egger, Matthias
    Fenner, Lukas
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2022, 181 (01) : 335 - 347
  • [33] Has the Legalisation of Medical and Recreational Cannabis Use in the USA Affected the Prevalence of Cannabis Use and Cannabis Use Disorders?
    Leung J.
    Chiu C.Y.V.
    Stjepanović D.
    Hall W.
    [J]. Current Addiction Reports, 2018, 5 (4) : 403 - 417
  • [34] Medical cannabis for children: Evidence and recommendations
    Kelly, Lauren E.
    Rieder, Michael J.
    Finkelstein, Yaron
    [J]. PAEDIATRICS & CHILD HEALTH, 2024, 29 (02) : 104 - 112
  • [35] Momentum grows for medical use of cannabis
    McCall, Chris
    [J]. LANCET, 2015, 386 (10004): : 1615 - 1616
  • [36] ETHICAL ISSUES IN MEDICAL CANNABIS USE
    Alexander, Steve
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 44 - 44
  • [37] Canadians' use of cannabis for therapeutic purposes since legalization of recreational cannabis: a cross-sectional analysis by medical authorization status
    Balneaves, Lynda G.
    Brown, Ashleigh
    Green, Matthew
    Prosk, Erin
    Rapin, Lucile
    Monahan-Ellison, Max
    Mcmillan, Eva
    Zaid, Jonathan
    Dworkind, Michael
    Watling, Cody Z.
    [J]. BMC MEDICINE, 2024, 22 (01) : 150
  • [38] Legalization of cannabis for medical and recreational use
    Hasin, D.
    [J]. EUROPEAN PSYCHIATRY, 2023, 66 : S20 - S21
  • [39] Use of Medical Cannabis for Respiratory Diseases
    Pechlivanidou, Rouzana
    Antoniadis, Andonis
    [J]. PNEUMON, 2018, 31 (02) : 67 - 70
  • [40] Ethical issues in medical cannabis use
    Sagy, Iftach
    Peleg-Sagy, Tal
    Barski, Leonid
    Zeller, Lior
    Jotkowitz, Alan
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2018, 49 : 20 - 22